Cooper Financial Group Gilead Sciences, Inc. Transaction History

Cooper Financial Group

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	BUY	$63.15 - $72.88 $281,838 - $325,263	4,463 Added 162.53%	7,209 $494,000
Q1 2024 Apr 11, 2024	SELL	$71.58 - $87.29 $20,829 - $25,401	-291 Reduced 9.58%	2,746 $201,000
Q4 2023 Jan 16, 2024	BUY	$73.27 - $83.09 $222,520 - $252,344	3,037 New	3,037 $246,000
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $41,979 - $47,827	543 Added 22.89%	2,915 $241,000
Q4 2022 Jan 13, 2023	BUY	$62.32 - $89.47 $147,823 - $212,222	2,372 New	2,372 $0
Q3 2020 Oct 09, 2020	SELL	$62.1 - $78.08 $284,666 - $357,918	-4,584 Closed	0 $0
Q2 2020 Jul 15, 2020	BUY	$72.34 - $84.0 $5,787 - $6,720	80 Added 1.78%	4,584 $353,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $19,290 - $24,707	308 Added 7.34%	4,504 $337,000
Q4 2019 Jan 07, 2020	BUY	$61.62 - $67.78 $12,015 - $13,217	195 Added 4.87%	4,196 $273,000
Q3 2019 Oct 08, 2019	BUY	$62.51 - $69.0 $24,816 - $27,393	397 Added 11.02%	4,001 $254,000
Q2 2019 Jul 08, 2019	BUY	$61.87 - $69.38 $9,218 - $10,337	149 Added 4.31%	3,604 $243,000
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $13,193 - $14,780	211 Added 6.5%	3,455 $225,000
Q4 2018 Jan 17, 2019	BUY	$60.54 - $79.0 $196,391 - $256,276	3,244 New	3,244 $203,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Cooper Financial Group, based on Form 13F filings with the SEC.

Stay updated on Cooper Financial Group with notifications on news.